We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+2.96%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$460M
AUM Growth
+$84.2M
Cap. Flow
+$106M
Cap. Flow %
23.1%
Top 10 Hldgs %
34.98%
Holding
99
New
18
Increased
56
Reduced
8
Closed
16

Top Buys

Rank Stock Value
1
COO icon
Cooper Companies
COO
+$14.6M
2
NBIX icon
Neurocrine Biosciences
NBIX
+$10.6M
3
BDX icon
Becton Dickinson
BDX
+$9.74M
4
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$9.13M
5
ZBH icon
Zimmer Biomet
ZBH
+$8.16M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$14.7M
2
CNCE
Concert Pharmaceuticals, Inc.
CNCE
+$7.03M
3
DHR icon
Danaher
DHR
+$5.95M
4
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$4.6M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$4.58M

Sector Composition

Rank Sector Weight
1 Healthcare 99.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMUX icon
76
Immunic
IMUX
$217M
$685K 0.15%
45,977
– –
WHWK
77
Whitehawk Therapeutics
WHWK
$269M
$550K 0.12%
+75,961
New +$812K
AFIB
78
DELISTED
Acutus Medical Inc
AFIB
$493K 0.11%
653,721
+601,694
+1,157% +$785K
TKNO icon
79
Alpha Teknova
TKNO
$397M
$448K 0.1%
151,255
+22,797
+18% +$114K
GRTS
80
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$422K 0.09%
+151,921
New +$434K
EWTX icon
81
Edgewise Therapeutics
EWTX
$4.73B
$415K 0.09%
62,283
+9,387
+18% +$87K
SVRA icon
82
Savara
SVRA
$1.17B
$346K 0.08%
+177,243
New +$399K
MLYS icon
83
Mineralys Therapeutics
MLYS
$2.38B
$157K 0.03%
+10,000
New +$168K
AGIO icon
84
Agios Pharmaceuticals
AGIO
$2.04B
– –
-50,000
Closed -$1.4M
ATEC icon
85
Alphatec Holdings
ATEC
$1.49B
– –
-226,867
Closed -$2.8M
CYTK icon
86
Cytokinetics
CYTK
$10.5B
– –
-25,000
Closed -$1.15M
EW icon
87
Edwards Lifesciences
EW
$53.6B
– –
-54,579
Closed -$4.07M
FULC icon
88
Fulcrum Therapeutics
FULC
$284M
– –
-206,866
Closed -$1.51M
GH icon
89
Guardant Health
GH
$22.2B
– –
-35,000
Closed -$952K
LFCR icon
90
Lifecore Biomedical
LFCR
$181M
– –
-203,578
Closed -$1.32M
CNSY
91
Cerenome, Inc. Common Stock
CNSY
$25.5M
– –
-1,556
Closed -$185K
RYTM icon
92
Rhythm Pharmaceuticals
RYTM
$8.1B
– –
-157,862
Closed -$4.6M
SGHT icon
93
Sight Sciences
SGHT
$456M
– –
-105,102
Closed -$1.28M
SRPT icon
94
Sarepta Therapeutics
SRPT
$1.94B
– –
-35,314
Closed -$4.58M
TMDX icon
95
Transmedics
TMDX
$3.02B
– –
-55,351
Closed -$3.42M
UBX
96
DELISTED
Unity Biotechnology
UBX
– –
-42,749
Closed -$117K
UNH icon
97
UnitedHealth
UNH
$364B
– –
-27,742
Closed -$14.7M
CNCE
98
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-1,203,484
Closed -$7.03M
OPNT
99
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
– –
-59,943
Closed -$1.22M
1 2 3
4

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return

Parkman Healthcare Partners's Q1 2023 Portfolio in Review

As of Q1 2023, Parkman Healthcare Partners held 99 positions worth $460M, up 22% from $376M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parkman Healthcare Partners deployed $106M of net new capital in Q1 2023, opening 18 new positions and adding to 56 existing holdings. Its largest new stake was Becton Dickinson: 39,788 shares worth $9.85M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 98% a quarter earlier.

On the sell side, the largest reduction was Danaher, an estimated $5.95M trimmed.

  • Parkman Healthcare Partners's largest Q1 2023 buy was Becton Dickinson: 39,788 shares worth $9.85M.
  • Parkman Healthcare Partners added most to Cooper Companies in Q1 2023, an estimated $14.6M increase.
  • Parkman Healthcare Partners's biggest Q1 2023 reduction was Danaher, cutting an estimated $5.95M.
  • Parkman Healthcare Partners fully exited UnitedHealth in Q1 2023, selling an estimated $14.7M.
  • Parkman Healthcare Partners's ten largest holdings make up 35% of its $460M portfolio in Q1 2023.
  • Parkman Healthcare Partners opened 18 new positions and closed 16 in Q1 2023.
  • Parkman Healthcare Partners's portfolio value rose 22% quarter-over-quarter to $460M.

Based on Parkman Healthcare Partners's 13F filing for Q1 2023, filed 12 May 2023.